ClinicalTrials.gg
RecruitingNCT06694532Updated Nov 19, 2024

EffIcacy Between Arthrocentesis With High Versus Low Molecular Weight Hyaluronic Acid in Treatment of TMJ Disorders

A Phase 1/2 interventional study of Hyaluronic acid and Syringes in Temporomandibular Joint Disorders and Arthrocentesis, sponsored by Basel khaled mohamed. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-11-19.

Sponsored by Basel khaled mohamed · Phase 1/2, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started Oct 2023; still recruiting 3 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1/2
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 63 studies in Temporomandibular Joint Disorders with a site in Egypt — 10 open to participants now, 14 under way, none of them phase 3. Temporomandibular Joint Disorders · Egypt.

Planned enrollment
23rd of 49
30 · median 30
Started
2023
with 11 others
Phase 1/2
Only one
of the 63
Primary completion
2026-02
later than 6 of 13 live
Registered
29th of 63
by date

Among the 63 studies in Temporomandibular Joint Disorders with a site in Egypt, this one is the 23rd largest by planned enrollment of the 49 interventional ones that give a count, is one of 12 that started in 2023, is the only one in phase 1/2, reaches primary completion later than 6 of the 13 other live ones, and was the 29th registered.

Temporomandibular Joint Disorders

593 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

Browse Temporomandibular Joint Disorders studies →

Open to participants now

10 of the 63 studies in Temporomandibular Joint Disorders with a site in Egypt are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 76 Temporomandibular Joint Disorders studies recruiting now, 26 (34%) set no upper age limit and 46 (61%) stop at 75 or younger; 7 take children under 18; 23 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 63 studies in Temporomandibular Joint Disorders with a site in Egypt, or all of them as a file.
02

Study summary

The study will be carried out in Patients in two Groups aged between 17 to 70 years , of both sexes, who had painful symptoms, with or without presence of joint noise, and had unilateral or bilateral internal derangement of the TMJ proven by clinical examination, with no improvement after conservative treatment.

Read the detailed description

The MEASUREMENT TOOL of the study will be carried out by 2 groups the first will be injected by high molecular weight hyaluronic acid and the second wil be injected by low molecular weight hyaluronic acid Then compare between Efectevness of injection of high-molecular weight versus Low moecular weight hyaluronic acid after two-needle arthrocentesis in improving the signs and symptoms of intra-articular TMJ disorder.

, 1- significantly improving the pain on scale 1-10 , and 2-significant improvements in mouth opening range in mm by the distance between the edges of the frontal incisors with a ruler or caliper and joint noise.

3-The presence of absence of clicking and cracking in jaw .

03

Conditions studied

  • Temporomandibular Joint Disorders
  • Arthrocentesis
04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pain or tenderness of the jaw
  • Pain in one or both of the temporomandibular joints
  • Aching pain in and around your ear
  • Difficulty chewing or pain while chewing
  • Aching facial pain
  • Locking of the joint,

Exclusion criteria

Exclusion Criteria:

  • Muscular TMJ disorders
  • Bleeding tendency
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    high molucular weight hyalurinic acid .

    patients injected e high molucular weight hyalurinic acid .

    Drug: Hyaluronic acid · Device: Syringes

  • Experimental
    low molcular weight hyaurinic acid

    patients injected with low molucular weight hyalurinic acid .

    Drug: Hyaluronic acid · Device: Syringes

Interventions

  • Comparative study between Hyalgan and Hyorth injectable products in TMJ Disorders by arthrocentesis of 2 syringes device

    Also known as: Arthrocentesis

  • DeviceSyringes

    Whilst you are asleep, two small needles will be inserted into the TMJ / Jaw Joint. One of these needles allows sterile saline to be pumped into the joint under pressure whilst the other needle allows the saline to drain out of the joint then injection of the HA injectiable products .

    Also known as: Arthrocentesis

06

What researchers measure

Primary outcomes

  1. EFFICACY between injection of high versus low molecular weight hyaluronic acid in TMJ arthrocentesis

    The MEASUREMENT TOOL of the study will be carried out by 2 groups the first will be injected by high molecular weight hyaluronic acid and the second wil be injected by low molecular weight hyaluronic acid Then compare between Efectevness of injection of high-molecular weight versus Low moecular weight hyaluronic acid after two-needle arthrocentesis in improving the signs and symptoms of intra-articular TMJ disorder. , 1- significantly improving the pain on scale 1-10 , and

    Time frame: 36 months

Secondary outcomes

  1. comparative between injection of high versus low molecular weight hyaluronic acid in TMJ arthrocentesis

    The MEASUREMENT TOOL of the study will be carried out by 2 groups the first will be injected by high molecular weight hyaluronic acid and the second wil be injected by low molecular weight hyaluronic acid Then compare between Efectevness of injection of high-molecular weight versus Low moecular weight hyaluronic acid after two-needle arthrocentesis in improving the signs and symptoms of intra-articular TMJ disorder. 2-significant improvements in mouth opening range in mm by the distance between the edges of the frontal incisors with a ruler or caliper and joint noise.

    Time frame: 36 months

07

Study locations

1 of 1 sites recruiting
  • Assiut Univeristy
    Assiut, 12346, Egypt
    Recruiting
    • Basel K Mohamed · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2023 (actual). Primary completion is estimated for Feb 2026, 27 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2023
First posted
Nov 19, 2024
StartActual
Oct 31, 2023
Primary completionEst.
Feb 1, 2026
CompletionEst.
Feb 28, 2026
Last update
Nov 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06694532
Lead sponsor
Basel khaled mohamed
Responsible party
Basel khaled mohamed (Assistant Lecturer, Assiut University) — Sponsor-investigator
First posted
Nov 19, 2024
Start date
Oct 31, 2023
Primary completion
Feb 1, 2026 (estimated)
Completion
Feb 28, 2026 (estimated)
Last update
Nov 19, 2024

Study contacts

Basel K Mohamed
Contact
Basel_shrider@yahoo.com
+201099848089
Basel K Mohamed
Contact
+201099848089
Basel K Mohamed
principal investigator · Assiut Univeristy

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Hyaluronic Acid

Start the discussion